Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > Wouldn't financing drive the price lower? +dilution & +debt?
View:
Post by JAInvestor on Aug 20, 2016 2:52pm

Wouldn't financing drive the price lower? +dilution & +debt?

J
Comment by wallop13 on Aug 20, 2016 5:17pm
No. Even if they were to issue 50,000 shares at $12 and put that money towards debt the share price would rise because the enterprise value would stay the same, but the bankruptcy risk would be lower. Hence the share price would rise. But the rise would be more limited because the market cap would rise twice as fast with double the shares.
Comment by wallop13 on Aug 20, 2016 5:21pm
Sorry. I meant to say 50 million shares. Not 50 thousand.
Comment by HamSandwich on Aug 20, 2016 6:12pm
Who in their right mind would be on the other side of that taking the 50 million shares at $12/share?  You really think there's an appetite for that? We're a lot more likely to see debt converted into equity and existing shareholders taking it up the pooper than we are to automagically issue $600 million worth of shares and also raise the value of all shares outstanding.
Comment by CNInvesting on Aug 20, 2016 7:36pm
This company's value is getting slimmer by the day. I don't think anyone would want to do equity financing at this point. I doubt even anyone would want to be doing debt financing. Too many players already have their slice of the pie on that side. No, I think they have nowhere to run for more deals and are doomed to run the business, which so far isn't going well.
Comment by wallop13 on Aug 20, 2016 8:21pm
Who knows. I was long, but not long or short right now. It's all so murky. Not sure what will end up happening. The management has really made a mess here. The torque that the debt now puts on this stock is joke. Shorts on black, longs on red, MT's spinning the the wheel. Doesn't make me feel too confident.    
Comment by LaticeInExile on Aug 20, 2016 8:42pm
This post has been removed in accordance with Community Policy
Comment by CNInvesting on Aug 20, 2016 9:02pm
It has to be a mistake...I mean even $1 million is enormous. It's like 1000 hours for lawyers charging 1000$/hour. Imagine if it were to be $100 million, I'm sure somebody would have said WTF.
Comment by LaticeInExile on Aug 20, 2016 9:05pm
This post has been removed in accordance with Community Policy
Comment by LaticeInExile on Aug 20, 2016 9:29pm
This post has been removed in accordance with Community Policy
Comment by CNInvesting on Aug 20, 2016 9:37pm
He's right that there's little value left to see in the NA portfolio. They bought worthless assets at a market high. Q2 transcript. https://seekingalpha.com/article/3999246-concordia-healthcares-cxrx-ceo-mark-thompson-q2-2016-results-earnings-call-transcript?page=1  
Comment by Juice004 on Aug 21, 2016 10:09am
Up until now the Covis Portfolio looked really good. They generated approximately 100M in revenue in the first 6 months of the year with gross margins around 86%. Not bad for a 1.2B acquisition. However, based on their reduced guidance for the 2 drugs that are seeing increased competition 100M seems to be the future annual revenue expectation now which would put the acquisition now at about 12X ...more  
Comment by LaticeInExile on Aug 21, 2016 10:34am
This post has been removed in accordance with Community Policy
Comment by CNInvesting on Aug 21, 2016 10:51am
Yeah and they were obligated to disclose it...otherwise business would be firing on all cylinders right now of course...
Comment by LaticeInExile on Aug 21, 2016 11:38am
This post has been removed in accordance with Community Policy
Comment by select1011 on Aug 21, 2016 2:23pm
This post has been removed in accordance with Community Policy
Comment by Juice004 on Aug 21, 2016 11:28am
With projections declining I estimate next year the whole NA segment should make 200M in revenues with margins ranging 85-88%. The international segment about 620M. An investor who is not as concerned with capital structure as they are with EBITDA or operating cash flows I think would be willing to pay 2.5X revenue for this segment and assume the 706M in long term debt from the Covis acquisition ...more  
Comment by LaticeInExile on Aug 21, 2016 11:56am
This post has been removed in accordance with Community Policy
Comment by Shane007 on Aug 21, 2016 12:36pm
LaticeinExile:  What is your position in CXRX?  Are you short?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities